US company Intrexon also engaged in marketing cloned bulls and genetically engineered insects
20 November 2015 / The US Food & Drug Administration (FDA) has cleared the way for the first genetically altered animals to reach American supermarkets. The salmon are engineered to grow much faster than normal through enhanced growth hormone production. This reduces both the time needed to raise the fish and feeding costs. A Canadian company acquired by Intrexon some years ago, will be raising the salmon. Intrexon is also actively engaged in marketing cloned bulls and genetically engineered insects. In Europe, Intrexon is known for its patents on genetically engineered chimpanzees.
Recent assessment of EFSA supports concerns regarding health risks
On 18 November, the Standing Committee on Plants, Animals, Food and Feed has three applications for the import authorisation of genetically engineered soybeans with resistance to glyphosate on its agenda. These soybeans can be used as food and feed across the EU. Two of these plants have been engineered to be resistant to the combined use of other herbicides and glyphosate. Testbiotech and GeneWatch UK are together requesting that these authorisation processes are suspended.
Report shows close networking between experts and industry
The results from the EU research project GRACE are to be presented in Potsdam, Germany on 9 and 10 November. The GRACE team of experts conducted feeding trials with genetically engineered plants on rats and reviewed existing publications on risk research. Testbiotech analysis shows the biotech industry has seriously impacted the results of the research project. As a Testbiotech report published today also shows, the biotech industry has not only systematically influenced the GRACE research project, but four other similar EU research projects.